Ovoca Bio

Ovoca Bio Overview

Founded 1985
Founded
Status Public
Employees 6
Employees
Stock Symbol OVXA
Stock Symbol
Investments 9
Share Price $0.14 (As of Friday Closing)

Ovoca Bio General Information

Description

Ovoca Bio PLC is a life science investment company. It is engaged in investing in the development and commercialisation of novel product candidates for the treatment of female sexual dysfunctions. The group has three business segments, exploration and pharmaceutical, which are operated principally in Russian Federation and investment activities operated from Bermuda, and with administrative activities in the Republic of Ireland. Its product candidate includes IVIX - Libicore - a novel synthetic peptide, administrated through a nasal spray.

Contact Information

Formerly Known As
Ovoca Resources
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Precious Metals and Minerals Mining
Other Industries
Gold Mining
Multi-line Mining
Stock Exchange
DUB
Primary Office
  • 17 Pembroke Street Upper
  • Dublin D02 AT22
  • Ireland
+353 (01) 000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ovoca Bio Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.14 $0.14 $0.06 - $0.28 $11.6M 7.58K -$0.04

Ovoca Bio Financials Summary

In Thousands,
USD
TTM 30-Jun-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017 FY 2016 31-Dec-2016
EV 6,617 4,683 680 2,774
EBITDA (2,320) (2,313) (211) (1,238)
Net Income (2,318) (2,780) (430) (1,061)
Total Assets 25,626 24,938 26,932 24,913
Total Debt 0 1,131 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ovoca Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ovoca Bio‘s full profile, request access.

Request a free trial

Ovoca Bio Executive Team (4)

Name Title Board Seat Contact Info
Kirill Golovanov JD Chief Executive Officer & Secretary
Svetlana Radchenko Ph.D Chief Financial Officer
Sergey Pakhomov Head Magadan Office

1 Former Executive

Ovoca Bio Board Members (2)

To view Ovoca Bio‘s full board member team, request access >>
Name Representing Role Since
0000000 0000000000 Ovoca Bio Board Member 000 0000

1 Former Board Member

Ovoca Bio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ovoca Bio‘s full profile, request access.

Request a free trial

Ovoca Bio Investments & Acquisitions (9)

To view Ovoca Bio‘s complete investment and acquisition history, request access >>
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 25-Sep-2018 000000000000000000 00.00 Drug Discovery 000000 000000000 00
00000 31-Mar-2010 000000000000000000 00.000 Precious Metals and Minerals Mining 0000000 0000000000
000000 31-Mar-2010 000000000000000000 000.00 Gold Mining 0000000 0000000000
00000 31-Mar-2010 000000000000000000 000.00 Gold Mining
Nevsko-Pestrinskoye, Stakhanovsky and Rassoshinskaya gold exploration and development projects 01-Jan-2010 Corporate Asset Purchase Buildings and Property

Ready to get started?

Request a free trial

Ovoca Bio Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 31-Mar-2010 000000000000000000 000.00 Completed
  • 00000 000
0000 00000000000 0 13-Sep-2007 000000000 00.00 Completed
  • 00000 000
Ayax Prospectors Artel 22-Dec-2005 Merger/Acquisition 000.00 Completed